Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Feb 25;288(6417):603–606. doi: 10.1136/bmj.288.6417.603

Effects of mild physical exercise on serum lipoproteins and metabolites of arachidonic acid: a controlled randomised trial in middle aged men.

R Rauramaa, J T Salonen, K Kukkonen-Harjula, K Seppänen, E Seppälä, H Vapaatalo, J K Huttunen
PMCID: PMC1444356  PMID: 6421395

Abstract

To study the effects of physical exercise on biochemical risk factors for ischaemic heart disease 31 healthy middle aged men undertook regular physical exercise for two months and 29 served as controls in a randomised trial. In the men taking regular exercise serum cholesterol concentrations increased 26% more in the high density lipoprotein subfraction two (HDL2) and decreased 31% more in the subfraction three (HDL3) and 9% more in the low density lipoprotein fraction than in the control group. A tendency towards increased plasma 6-keto-prostaglandin F1 alpha concentration and decreased serum thromboxane B2 concentration was found during the period of regular exercise, but prostaglandin E2 concentrations remained unchanged. The increase in plasma 6-keto-prostaglandin F1 alpha concentration was associated with an increase in serum HDL2 cholesterol concentration in the group taking regular exercise. Our data suggest that mild regular physical exercise favourably influences cholesterol distribution in serum lipoproteins in healthy middle aged men and may have beneficial effects on circulating metabolites of arachidonic acid.

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers J. J., Chen C. H., Aladjem F. Human serum lipoproteins. Evidence for three classes of lipoproteins in S fO-2. Biochemistry. 1972 Jan 4;11(1):57–63. doi: 10.1021/bi00751a011. [DOI] [PubMed] [Google Scholar]
  2. Burghuber O., Sinzinger H., Silberbauer K., Wolf C., Haber P. Decreased prostacyclin sensitivity of human platelets after jogging and squash. Prostaglandins Med. 1981 Feb;6(2):127–130. doi: 10.1016/0161-4630(81)90082-3. [DOI] [PubMed] [Google Scholar]
  3. Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970 Nov;11(6):583–595. [PubMed] [Google Scholar]
  4. Demers L. M., Harrison T. S., Halbert D. R., Santen R. J. Effect of prolonged exercise on plasma prostaglandin levels. Prostaglandins Med. 1981 Apr;6(4):413–418. doi: 10.1016/0161-4630(81)90073-2. [DOI] [PubMed] [Google Scholar]
  5. Ehnholm C., Huttunen J. K., Pietinen P., Leino U., Mutanen M., Kostiainen E., Pikkarainen J., Dougherty R., Iacono J., Puska P. Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med. 1982 Sep 30;307(14):850–855. doi: 10.1056/NEJM198209303071403. [DOI] [PubMed] [Google Scholar]
  6. Fleisher L. N., Tall A. R., Witte L. D., Miller R. W., Cannon P. J. Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem. 1982 Jun 25;257(12):6653–6655. [PubMed] [Google Scholar]
  7. Gofman J. W., Young W., Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation. 1966 Oct;34(4):679–697. doi: 10.1161/01.cir.34.4.679. [DOI] [PubMed] [Google Scholar]
  8. Huttunen J. K., Länsimies E., Voutilainen E., Ehnholm C., Hietanen E., Penttilä I., Siitonen O., Rauramaa R. Effect of moderate physical exercise on serum lipoproteins. A controlled clinical trial with special reference to serum high-density lipoproteins. Circulation. 1979 Dec;60(6):1220–1229. doi: 10.1161/01.cir.60.6.1220. [DOI] [PubMed] [Google Scholar]
  9. Kirstein P., Carlson K. Determination of the cholesterol content of high density lipoprotein subfractions HDL2 and HDL3, without contamination of Lp(a), in human plasma. Clin Chim Acta. 1981 Jun 18;113(2):123–134. doi: 10.1016/0009-8981(81)90146-7. [DOI] [PubMed] [Google Scholar]
  10. Miller N. E., Thelle D. S., Forde O. H., Mjos O. D. The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study. Lancet. 1977 May 7;1(8019):965–968. doi: 10.1016/s0140-6736(77)92274-7. [DOI] [PubMed] [Google Scholar]
  11. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  12. Morris J. N., Chave S. P., Adam C., Sirey C., Epstein L., Sheehan D. J. Vigorous exercise in leisure-time and the incidence of coronary heart-disease. Lancet. 1973 Feb 17;1(7799):333–339. doi: 10.1016/s0140-6736(73)90128-1. [DOI] [PubMed] [Google Scholar]
  13. Nordøy A., Svensson B., Wiebe D., Hoak J. C. Lipoproteins and the inhibitory effect of human endothelial cells on platelet function. Circ Res. 1978 Oct;43(4):527–534. doi: 10.1161/01.res.43.4.527. [DOI] [PubMed] [Google Scholar]
  14. Risk C., Rie M., Peterson M., Kong D., Woods B., Watkins W. D. Thromboxane and prostacyclin (epoprostenol) during exercise in diffuse pulmonary fibrosis. Lancet. 1982 Nov 27;2(8309):1183–1185. doi: 10.1016/s0140-6736(82)91202-8. [DOI] [PubMed] [Google Scholar]
  15. Ritter J. M., Barrow S. E., Blair I. A., Dollery C. T. Release of prostacyclin in vivo and its role in man. Lancet. 1983 Feb 12;1(8320):317–319. doi: 10.1016/s0140-6736(83)91626-4. [DOI] [PubMed] [Google Scholar]
  16. Salonen J. T., Puska P., Tuomilehto J. Physical activity and risk of myocardial infarction, cerebral stroke and death: a longitudinal study in Eastern Finland. Am J Epidemiol. 1982 Apr;115(4):526–537. doi: 10.1093/oxfordjournals.aje.a113334. [DOI] [PubMed] [Google Scholar]
  17. Sinzinger H., Feigl W., Silberbauer K. Prostacyclin generation in atherosclerotic arteries. Lancet. 1979 Sep 1;2(8140):469–469. doi: 10.1016/s0140-6736(79)91520-4. [DOI] [PubMed] [Google Scholar]
  18. Szczeklik A., Gryglewski R. J. Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery. 1980;7(6):488–495. [PubMed] [Google Scholar]
  19. Wood P. D., Haskell W. L., Blair S. N., Williams P. T., Krauss R. M., Lindgren F. T., Albers J. J., Ho P. H., Farquhar J. W. Increased exercise level and plasma lipoprotein concentrations: a one-year, randomized, controlled study in sedentary, middle-aged men. Metabolism. 1983 Jan;32(1):31–39. doi: 10.1016/0026-0495(83)90152-x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES